This summer, we have been fortunate enough to have been asked to speak at the 2017 Association of Healthcare Resource and Materials Management conference (AHRMM17). The organization is the premier membership group for healthcare supply chain professionals and we’re honored to have been invited back to speak. This year, we will present “Value Analysis and Evidence: The Keys to Bundled Payment Success."Read More
Despite the instability facing the American healthcare landscape at present, there continues to be growing focus on value. The Patient Protection and Affordable Care Act (ACA) has placed an increased emphasis on healthcare quality and patient satisfaction, especially with regard to Medicare reimbursement. Private payers are also seeking payment structures based on patient outcomes. In the face of such economic pressures, deciding which technologies to incorporate into patient care is a challenge, and will continue to be so in the future as new health technologies and brands enter the market. To meet clinical as well as financial goals, providers need to make sure that the health technologies they adopt are safe and have proven benefit, and are cost-effective.Read More
We get it. Time is valuable. Particularly your own. Whether you are a payer, a healthcare provider, or a supply chain or value analysis professional, you have to make the most of the time you have to get your job done. When it comes to your search for evidence to determine whether a medical technology is safe, efficacious, and the best option, maybe you only read the abstract of an original research article for a quick overview of the results. Perhaps you couldn’t access the full text of the article without incurring a charge. The truth is, we have all done it at one point or another, primarily because we believe that the abstract provides an accurate synopsis of the highlights of the study.
In many cases, however, it doesn’t.Read More
We have reached the end of our 4-part series! We hope you and your fellow supply chain and value analysis professionals found the information useful and have shared it with your peers. Don’t forget, you can also download our free eBook, Evidence: The 5th Domain of Value-Based Purchasing to read the content of this series in one complete package.
Didn’t read part 3? Here’s part 3.
Without further ado, we will review our fourth and final VBP domain as well as talk about the link between evidence and executive compensation.Read More
Welcome back for part 3 of our 4-part series! We’re just past the halfway mark in our effort to tell you about the impact of evidence on value-based purchasing (VBP). If you found the previous installments informative, please share these blogs with your fellow supply chain and value analysis professionals. Don’t forget, you can also download our free eBook, Evidence: The 5th Domain of Value-Based Purchasing to read the content of this series in one complete package.
Need to catch up? Here’s part 2.
Let’s review our third VBP domain: Clinical Care (Outcomes and Process).Read More
Welcome back for part 2 of our 4-part series about the impact of evidence on value-based purchasing (VBP). We hope you found the first installment informative, and that you shared it with your fellow supply chain and value analysis professionals. Don’t forget, you can download our free eBook, Evidence: The 5th Domain of Value-Based Purchasing to read the content of this series in one complete package.
Need a refresher for part 1? Read it here.
Let’s move on to our next VBP domain: Efficiency and Cost Reduction.Read More
If you are a subscriber to our blog or any of our services (and if you aren’t, what are you waiting for?), it is no secret that we talk quite a bit about evidence and its vital necessity to the advancement of healthcare delivery. But without establishing some context by defining it, exploring what makes good evidence, and why it is important, our conversations about evidence can seem empty; the word becomes just another term in our promotional materials. With that, let us take a deeper look at what scientific evidence is and why it is the foundation of what we do here at Hayes.Read More
There’s been much conversation recently about the fate of value-based purchasing and the move from fee-for-service to outcomes-based medicine. Established by the Patient Protection and Affordable Care Act (ACA), the Hospital Value-Based Purchasing (VBP) Program is an initiative set forth by the Centers for Medicare & Medicaid Services (CMS) to provide acute-care hospitals with incentive payments based on the quality of care provided to their Medicare beneficiaries. These payments are based not only on how well the hospitals perform on each approved measure, but also on how much they improve compared with their performance that was established during a predetermined baseline period.Read More
If you are a regular reader of our blog, you know we use a number of terms quite often. Fiercely unbiased. Critical appraisal. Scientific rigor.
But whether you’re a payer or a provider, a current or potential client: what does any of that mean to you? Why are these terms important, and how can the fact that they make up the DNA of what we do enhance your coverage policy determination and value analysis and value-based purchasing initiatives?
Last week, I had the distinct privilege of presenting the keynote at the first annual Northeast Regional Conference of the Association of Healthcare Value Analysis Professionals (AHVAP). With the ever-increasing push away from fee-for-service and toward value-based healthcare, I thought it pertinent to discuss the role of value analysis in the success of a health system’s bundled payment initiatives. Specifically, I wanted to highlight the role evidence can play in assisting value analysis professionals in their evidence-based decision making, as well as how it can help them define the part they play in the value-based purchasing environment.Read More